Search results for " papi"

showing 10 items of 306 documents

Human papillomavirus-associated cancers: a survey on otorhinolaryngologists' knowledge and attitudes on prevention.

2016

Human papillomavirus (HPV) infection is a recognised causal factor associated with oropharyngeal cancers. The global burden of HPVrelated oropharyngeal cancers is on the increase and is predicted to surpass the burden of cervical cancer in the near future. As evidence is accumulating on the potential effectiveness of an HPV vaccine in controlling the oropharyngeal cancer epidemic; otorhinolaryngologists assume a key role - not only in the diagnosis and treatment of HPV-related cancers - but also in educating and advocating on HPV prevention. We conducted a survey to assess Italian otorhinolaryngologists' knowledge and attitudes regarding HPV infection, HPV-related oropharyngeal diseases and…

Health Knowledge Attitudes PracticeHuman papillomavirusPrimary preventionHead and Neck NeoplasmPapillomavirus InfectionsEuropeOtolaryngologyHuman papillomaviruKnowledgeItalyHead and Neck NeoplasmsNeoplasmsSurveys and QuestionnairesHumansFemalePapillomavirus VaccinesPapillomavirus VaccineHead and NeckActa otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale
researchProduct

Factors Associated with HPV Vaccine Refusal among Young Adult Women after Ten Years of Vaccine Implementation

2018

In Italy, the Human Papillomavirus (HPV) vaccination was implemented for twelve years old girls in 2007, but its coverage was lower than the recommended level. Sicily is one of the Italian administrative regions with lower vaccination coverage, with a value of 59% for those born in 1996 increasing to 62% coverage for those born in 1999. The aim of the study was to investigate factors associated with the refusal of HPV vaccination among young adult women of Palermo, Italy. The study was approved by the Ethics Committee of the Policlinico “Paolo Giaccone” Hospital (Palermo 1) and the questionnaire was validated in a convenience sample representing 10% of the young women. A cross-s…

Health Knowledge Attitudes PracticeVaccination scheduleHealth Toxicology and Mutagenesislcsh:MedicineSettore MED/42 - Igiene Generale E Applicata0302 clinical medicineVaccination RefusalSurveys and QuestionnairesHealth belief model030212 general & internal medicineYoung adulthuman papillomavirusResponse rate (survey)education.field_of_study030219 obstetrics & reproductive medicineVaccinationHPV infectionVaccinationItalyFemalewomencatch upAdultmedicine.medical_specialtyAdolescenthuman papillomavirus; vaccine refusal; hesitancy; women; school based; Health Belief Model; gynaecologist; general practitioner; survey; catch upPopulationArticleYoung Adult03 medical and health sciencesschool basedmedicineHumanssurveyPapillomavirus Vaccineseducationbusiness.industryPublic healthPapillomavirus Infectionslcsh:RPublic Health Environmental and Occupational Healthmedicine.diseasegynaecologistCross-Sectional StudiesHuman papillomaviruFamily medicinegeneral practitionervaccine refusalhesitancybusinessCatch up; General practitioner; Gynaecologist; Health Belief Model; Hesitancy; Human papillomavirus; School based; Survey; Vaccine refusal; Women; Public Health Environmental and Occupational Health; Health Toxicology and MutagenesisHealth Belief ModelInternational Journal of Environmental Research and Public Health; Volume 15; Issue 4; Pages: 770
researchProduct

Drivers for human papillomavirus vaccination in Valencia (Spain)

2018

Objective: To describe the drivers associated with HPV vaccination in adolescent girls and their parent's opinion on the vaccine. Methods: We conducted an observational and cross-sectional study on adolescent girls and their parents in Valencia (Spain), between September 2011 and June 2012. A consultation was made at a random sample of schools of the 14-year-old girls that should have received the vaccine in the free vaccination programme. We ran a personal survey on knowledge and attitudes regarding HPV infection and the vaccine. A binary logistic regression model was performed to determine which factors were most associated with vaccination. Results: The survey was run on a binomial of 1,…

Health Knowledge Attitudes Practicemedicine.medical_specialtyHuman papillomavirusAdolescentDriversCross-sectional studyCulturePsychology AdolescentMothersLogistic regressionSampling Studies03 medical and health sciences0302 clinical medicineVaccination RefusalInfermeriamedicineHumansPapillomavirus Vaccines030212 general & internal medicineVacunacióMotivationVaccines030505 public healthImmunization Programsbusiness.industryNurselcsh:Public aspects of medicinePapillomavirus InfectionsVaccinationPublic Health Environmental and Occupational HealthHPV infectionlcsh:RA1-1270Patient Acceptance of Health Caremedicine.diseaseCountry of originConfidence intervalSurgeryVaccination RefusalVaccinationCross-Sectional StudiesSpainFamily medicineAttitudesFemaleObservational study0305 other medical sciencebusiness
researchProduct

Intraductal tubulopapillary neoplasm (ITPN) of the pancreas: a distinct entity among pancreatic tumors

2022

Aims Intraductal tubulopapillary neoplasm (ITPN) of the pancreas is a recently recognized pancreatic tumor entity. Here we aimed to determine the most important features with a systematic review coupled with an integrated statistical approach. Methods and results PubMed, SCOPUS, and Embase were searched for studies reporting data on pancreatic ITPN. The clinicopathological, immunohistochemical, and molecular data were summarized. Then a comprehensive survival analysis and a comparative analysis of the molecular alterations of ITPN with those of pancreatic ductal adenocarcinoma (PDAC) and intraductal papillary mucinous neoplasm (IPMN) from reference cohorts (including the International Cance…

HistologyIPMNITPNPancreatic Intraductal NeoplasmsPDACpancreatic ductal adenocarcinomaGeneral MedicineCarcinoma PapillaryPathology and Forensic MedicinePancreatic Neoplasmspancreatubulopapillary.TubulopapillaryHumansintraductalPrecision MedicineIPMN; ITPN; Intraductal; PDAC; Tubulopapillary; pancreas; pancreatic ductal adenocarcinomaPancreasCarcinoma Pancreatic Ductal
researchProduct

Spontaneous Remission of Recalcitrant Warts in Girls After Human Papillomavirus Vaccination

2016

Histologybusiness.industrySpontaneous remissionDermatologyVirologyHuman papillomavirus vaccinationPathology and Forensic Medicine030207 dermatology & venereal diseases03 medical and health sciencesRemission inductionPapillomavirus Vaccines0302 clinical medicine030220 oncology & carcinogenesisImmunologyMedicinebusinessActas Dermo-Sifiliográficas (English Edition)
researchProduct

HPV group- and type-specific concordance in HPV infected sexual couples.

2007

The concordance of human papillomavirus (HPV) groups and types was evaluated in 45 sexual couples with both partners HPV infected, by analyzing cervical samples from women and three genital sites (penile brushing, urethral brushing, and semen) from men. When grouping HPV types, no significant HPV group sharing was found between partners, either considering samples from any male site (concordance: 55.5%; P = 0.11) or from each site (concordance by penile brushing, 37.8%; urethral brushing, 24.5%; semen, 22.3%; P > 0.05). Examining individual HPV types, using samples from any male site, concordance was found in 29 (64.4%; P = 0.036) couples; significant concordance was evident for 16 HPV geno…

Hpv genotypesAdultMalemedicine.medical_specialtyPenile DiseasesConcordanceSemenhuman papillomavirus (HPV) concordance sexual partnersAlphapapillomavirusUterine Cervical DiseasesVirologymedicineHumansSex organHuman papillomavirusGynecologyHpv typesbusiness.industryPapillomavirus InfectionsType specificMiddle AgedInfectious DiseasesSexual PartnersDNA ViralFemalebusinessJournal of medical virology
researchProduct

Potential impact of a nonavalent anti HPV vaccine in Italian men with and without clinical manifestations

2021

AbstractHuman papilloma virus infection (HPV) is the most common sexually transmitted disease. Little is known about male infection. Nonavalent vaccine against types 6/11/16/18/31/33/45/52/58 was approved and neutral gender immunization programs have been proposed. This study evaluates the potential impact of nonavalent vaccine compared to quadrivalent in male living in Sicily (Italy). 58.7% of samples were HPV positive and forty-four types of HPV were identified. A significant higher estimated coverage of nonavalent vaccine than quadrivalent was observed (64.3% vs. 45.8%), with absolute and relative additional impact of 20.1% and 47.2%, respectively. Low impact of the vaccine were calculat…

Hpv genotypesSexually transmitted diseaseAdultMalemedicine.medical_specialtyScienceDiseasesMicrobiologyArticle03 medical and health sciencesYoung Adult0302 clinical medicineMedical researchHuman Papillomavirus Recombinant Vaccine Quadrivalent Types 6 11 16 18Internal medicineMedicineHumansHuman papilloma virus infection030212 general & internal medicinePapillomavirus VaccinesPapillomaviridaeSicilyAgedPotential impactMultidisciplinarybusiness.industryHPV PositivePapillomavirus InfectionsQHealth careRMiddle Aged030220 oncology & carcinogenesisCase-Control StudiesMedicinebusinessSexual contactHPV nonavalent vaccine men infectious desease
researchProduct

Polyethylenimine is a strong inhibitor of human papillomavirus and cytomegalovirus infection.

2012

ABSTRACT Polyethylenimines are cationic polymers with potential as delivery vectors in gene therapy and with proven antimicrobial activity. However, the antiviral activity of polyethylenimines has not been addressed in detail thus far. We have studied the inhibitory effects of a linear 25-kDa polyethylenimine on infections with human papillomaviruses and human cytomegaloviruses. Preincubation of cells with polyethylenimine blocked primary attachment of both viruses to cells, resulting in a significant reduction of infection. In addition, the dissemination of human cytomegalovirus in culture cells was efficiently reduced by recurrent administration of polyethylenimine. Polyethylenimine conce…

Human cytomegalovirusKeratinocytesGenetic enhancementCongenital cytomegalovirus infectionCytomegalovirusVirus AttachmentBiologyAntiviral Agentschemistry.chemical_compoundCationsChlorocebus aethiopsmedicineCytotoxic T cellAnimalsHumansPolyethyleneiminePharmacology (medical)Human papillomavirusPapillomaviridaePharmacologyPolyethyleniminePapillomavirus InfectionsFibroblastsAntimicrobialmedicine.diseaseVirologyMicrobicides for sexually transmitted diseasesInfectious DiseasesHEK293 CellschemistryMicroscopy FluorescenceOrgan SpecificityCOS CellsCytomegalovirus InfectionsHeLa CellsAntimicrobial agents and chemotherapy
researchProduct

The Role of Micronutrients in Human Papillomavirus Infection, Cervical Dysplasia, and Neoplasm

2023

There is evidence that diet and nutrition are modifiable risk factors for several cancers. In recent years, attention paid to micronutrients in gynecology has increased, especially regarding Human papillomavirus (HPV) infection. We performed a review of the literature up until December 2022, aiming to clarify the effects of micronutrients, minerals, and vitamins on the history of HPV infection and the development of cervical cancer. We included studies having as their primary objective the evaluation of dietary supplements, in particular calcium; zinc; iron; selenium; carotenoids; and vitamins A, B12, C, D, E, and K. Different oligo-elements and micronutrients demonstrated a potential prote…

Human papillomaviruMicronutrients.Cervical cancerSettore MED/40 - Ginecologia E OstetriciaCervical dysplasiaCancer prevention
researchProduct

Adverse reactions to human papillomavirus vaccine in the Valencian Community (2007-2011)

2014

Resumen: Introducción: En 2009, 2 casos de convulsiones en adolescentes tras la administración de la vacuna tetravalente frente al virus del papiloma humano (VPH) generaron impacto mediático y afectaron negativamente la confianza del público en esta vacuna.Nuestros objetivos fueron describir las sospechas de reacciones adversas (SRA) notificadas al Centro Autonómico de Farmacovigilancia de la Comunidad Valenciana (CAFCV) tras la administración de la vacuna frente al VPH y comparar la tasa de notificación de síncope y convulsiones de esta vacuna con la de otras vacunas administradas en adolescentes. Material y métodos: Estudio descriptivo de las notificaciones de SRA relacionadas con esta va…

Human papillomavirusVacunaReacción adversaVirus del papiloma humanoTasa de notificaciónPediatricsRJ1-570Reporting ratePharmacovigilanceFarmacovigilanciaPediatrics Perinatology and Child HealthEnfermeríaAdverse reactionsVaccine
researchProduct